From the MS Center Amsterdam (H.V., A.d.S., V.W.), Amsterdam Neuroscience, Department of Radiology and Nuclear Medicine, Amsterdam UMC (M.P.), the Netherlands; Wellcome Centre for Integrative Neuroimaging (WIN), FMRIB (M.J.), Nuffield Department of Clinical Neurosciences (NDCN), University of Oxford, UK; Human Imaging and Image Processing Core (D.L.P.), Center for Neuroscience and Regenerative Medicine, The Henry M. Jackson Foundation, Bethesda, MD; Center for Neurological Imaging (C.R.G.G.), Department of Radiology, Brigham and Women's Hospital, Boston, MA; Section of Neuroradiology (Department of Radiology) (D.P.), Vall d'Hebron University Hospital and Research Institute (VHIR), Autonomous University Barcelona, Spain; Neuroimaging Research Unit (M.A.R.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; AMIGO (M.J.C.), School of Biomedical Engineering and Imaging Sciences, King's College London; and Institutes of Neurology & Healthcare Engineering (F.B.), UCL London, UK.
Neurology. 2021 Nov 23;97(21):989-999. doi: 10.1212/WNL.0000000000012884. Epub 2021 Oct 4.
Patients with multiple sclerosis (MS) have heterogeneous clinical presentations, symptoms, and progression over time, making MS difficult to assess and comprehend in vivo. The combination of large-scale data sharing and artificial intelligence creates new opportunities for monitoring and understanding MS using MRI. First, development of validated MS-specific image analysis methods can be boosted by verified reference, test, and benchmark imaging data. Using detailed expert annotations, artificial intelligence algorithms can be trained on such MS-specific data. Second, understanding disease processes could be greatly advanced through shared data of large MS cohorts with clinical, demographic, and treatment information. Relevant patterns in such data that may be imperceptible to a human observer could be detected through artificial intelligence techniques. This applies from image analysis (lesions, atrophy, or functional network changes) to large multidomain datasets (imaging, cognition, clinical disability, genetics). After reviewing data sharing and artificial intelligence, we highlight 3 areas that offer strong opportunities for making advances in the next few years: crowdsourcing, personal data protection, and organized analysis challenges. Difficulties as well as specific recommendations to overcome them are discussed, in order to best leverage data sharing and artificial intelligence to improve image analysis, imaging, and the understanding of MS.
多发性硬化症(MS)患者的临床表现、症状和随时间的进展存在异质性,这使得 MS 在体内评估和理解变得困难。大规模数据共享和人工智能的结合为使用 MRI 监测和理解 MS 创造了新的机会。首先,可以通过验证的参考、测试和基准成像数据来促进经过验证的 MS 特定图像分析方法的开发。使用详细的专家注释,可以在这种 MS 特定的数据上训练人工智能算法。其次,通过具有临床、人口统计学和治疗信息的大型 MS 队列的共享数据,可以极大地推进对疾病过程的理解。通过人工智能技术,可以检测到这种数据中可能对人类观察者不可察觉的相关模式。这适用于从图像分析(病变、萎缩或功能网络变化)到大型多域数据集(成像、认知、临床残疾、遗传学)。在回顾了数据共享和人工智能之后,我们强调了 3 个在未来几年内有很大机会取得进展的领域:众包、个人数据保护和有组织的分析挑战。为了充分利用数据共享和人工智能来改善图像分析、成像和对 MS 的理解,讨论了困难和克服这些困难的具体建议。